Compound information
- Natural Products
- ZC842254
- Molecular Formula
- C13H17NO4
- Molecular Weight
- 251.115758024 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(benzyloxycarbonylamino)pentanoic acid
- InChI
- InChI=1S/C13H17NO4/c1-2-6-11(12(15)16)14-13(17)18-9-10-7-4-3-5-8-10/h3-5,7-8,11H,2,6,9H2,1H3,(H,14,17)(H,15,16)/t11-/m0/s1
- InChI Key
- NSJDRLWFFAWSFP-NSHDSACASA-N
- SMILES
- CCC[C@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000001638000
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 2.399 |
LogS | -3.033 | LogD | 1.302 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.002 |
HIA | 0.891 | F20 % | 0.991 |
F30 % | 0.76 | Caco-2 | -5.19 |
MDCK | -4.761 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.909 | PPB | 80.249 |
VD | 0.428 | Fu | 0.613 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.006 | CYP1A2 substrate | 0.704 |
CYP2A6 substrate | 0.433 | CYP2B6 substrate | 0.493 |
CYP2C19 inhibitor | 0.096 | CYP2C19 substrate | 0.864 |
CYP2C8 substrate | 0.747 | CYP2C9 inhibitor | 0.081 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.038 |
CYP2D6 substrate | 0.472 | CYP2E1 substrate | 0.3 |
CYP3A4 inhibitor | 0.017 | CYP3A4 substrate | 0.869 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.818 | CL | 2.519 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.001 | Hepatotoxicity | 0.732 |
Mutagenicity | 0.009 | Rat Oral Acute Toxicity | 0.026 |
FDAMDD | 0.04 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.01 | Eye Corrosion | 0.008 |
Eye Irritation | 0.267 | Respiratory Toxicity | 0.003 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.344 | IGC50 | 2.035 |
LC50FM | 3.494 | LC50DM | 4.427 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.254 | NR-AR-LBD | 0.263 |
NR-AhR | 0.003 | NR-Aromatase | 0.044 |
NR-ER | 0.308 | NR-ER-LBD | 0.314 |
NR-PPAR-gamma | 0.53 | SR-ARE | 0.03 |
SR-ATAD5 | 0.324 | SR-HSE | 0.084 |
SR-MMP | 0.009 | SR-p53 | 0.021 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.